Literature DB >> 16329036

Detection of anti-Mullerian hormone receptor II protein in the postnatal rat testis from birth to sexual maturity.

S M L C Mendis-Handagama1, N Di Clementi, H B S Ariyaratne, L Mrkonjich.   

Abstract

Anti-Mullerian hormone (AMH) produced by the immature Sertoli cells negatively regulates the postnatal Leydig cell (i.e. adult Leydig cells/ALC) differentiation, however, the mechanism is sparsely understood. AMH negatively regulates the steroidogenic function of fetal Leydig cells (FLC) and ALC. However, when this function is established in the ALC lineage and whether AMH has a function in FLC in the postnatal testis are not known. Therefore, the objectives of this study were to examine the presence of AMH receptor type II (AMHR-II) in FLC and cells in the ALC lineage in the postnatal mammalian testis using the rat model Male Sprague Dawley rats of days 1, 5, 7-21, 28, 40, 60 and 90 were used. AMHR-II in testicular interstitial cells was detected in testis tissue using immunocytochemistry. Findings showed that the mesenchymal and the progenitor cells of the ALC lineage, were negative for AMHR-II. The newly formed ALC were the first cell type of the ALC lineage to show positive labeling for AMHR-II, and the first detection was on postnatal day 13, although they were present in the testis from day 10. From days 13-28, labeling intensity for AMHR-II in the ALC was much weaker than those at days 40-90. FLC were also positive. The time lag between the first detection of the newly formed ALC in the testis and the first detection of AMHR-II in them suggests that the establishment of the negative regulatory role of AMH on ALC steroidogenesis does not take place immediately upon their differentiation; no change in cell size occurs during this period. The absence of AMHR-II in mesenchymal cells suggests that it is unlikely that the negative regulatory effect of AMH on ALC differentiation in the postnatal testis is achieved via a direct action of AMH on mesenchymal cells. The presence of AMHR-II in postnatal FLC suggests a possible role by AMH on FLC, which warrants future investigations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16329036     DOI: 10.14670/HH-21.125

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  Adult testicular dysgenesis of Inhba conditional knockout mice may also be caused by disruption of cross-talk between Leydig cells and germ cells.

Authors:  Zhijian Sun; Zhen Li; Yuanqiang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-05       Impact factor: 11.205

2.  Regulation of the gonadal transcriptome during sex determination and testis morphogenesis: comparative candidate genes.

Authors:  Tracy M Clement; Matthew D Anway; Mehmet Uzumcu; Michael K Skinner
Journal:  Reproduction       Date:  2007-09       Impact factor: 3.906

3.  Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study.

Authors:  Fahimeh Ramezani Tehrani; Mohammad Ali Mansournia; Masoud Solaymani-Dodaran; Sonia Minooee; Fereidoun Azizi
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

Review 4.  Insights into the Development of the Adult Leydig Cell Lineage from Stem Leydig Cells.

Authors:  Leping Ye; Xiaoheng Li; Linxi Li; Haolin Chen; Ren-Shan Ge
Journal:  Front Physiol       Date:  2017-06-28       Impact factor: 4.566

5.  The Nuclear Receptor COUP-TFII Regulates Amhr2 Gene Transcription via a GC-Rich Promoter Element in Mouse Leydig Cells.

Authors:  Samir Mehanovic; Raifish E Mendoza-Villarroel; Robert S Viger; Jacques J Tremblay
Journal:  J Endocr Soc       Date:  2019-10-01

6.  Dietary Fibre Supplementation Improves Semen Production by Increasing Leydig Cells and Testosterone Synthesis in a Growing Boar Model.

Authors:  Yan Lin; Lianqiang Che; Zhengfeng Fang; Shengyu Xu; Bin Feng; Yong Zhuo; Jian Li; Caimei Wu; Junjie Zhang; Lujie Li
Journal:  Front Vet Sci       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.